Skip to main content
Top

Drugs

Issue 5/2021

Content (12 Articles)

Open Access Respiratory Syncytial Virus Infection Current Opinion

MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19

Christine Hum, Julia Loiselle, Nadine Ahmed, Tyler A. Shaw, Caroline Toudic, John Paul Pezacki

Ebola Virus AdisInsight Report

Ansuvimab: First Approval

Arnold Lee

Breast Cancer AdisInsight Report

Margetuximab: First Approval

Anthony Markham

Lupus Nephritis AdisInsight Report

Voclosporin: First Approval

Young-A Heo

Open Access Addiction Letter to the Editor

Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”

Udo Bonnet, Heath McAnally, Norbert Scherbaum

Addiction Letter to the Editor

Authors’ Reply to Bonnet et al. “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”

Kirk E. Evoy, Sarvnaz Sadrameli, Jillian Contreras, Jordan R. Covvey, Alyssa M. Peckham

Open Access Correction

Correction to: Lonafarnib: First Approval

Sohita Dhillon